Surgical Protocols, Treatment Protocols
Gynecologic, Ovarian, Ovarian Metastatic
A Phase I/II Study of Ruxolitinib with Front-Line Neoadjuvant and Post-Surgical Therapy in Patients with Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Study open to Phase II accrual.
This protocol has additional regulatory requirements to be completed prior to registering any patients at your site. Please contact Amber Boerner at 406-969-6067 or firstname.lastname@example.org for additional information.